These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24226313)

  • 21. Angiotensin receptor blockers for management of hypertension.
    Catanzaro DF; Frishman WH
    South Med J; 2010 Jul; 103(7):669-73. PubMed ID: 20531060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapy for hypertension associated with kidney disease].
    Suzuki H
    Nihon Naika Gakkai Zasshi; 2003 Feb; 92(2):264-9. PubMed ID: 12652731
    [No Abstract]   [Full Text] [Related]  

  • 24. Antihypertensive medication use is associated with increased organ system involvement and hospitalization in emergency department patients with anaphylaxis.
    Lee S; Hess EP; Nestler DM; Bellamkonda Athmaram VR; Bellolio MF; Decker WW; Li JT; Hagan JB; Manivannan V; Vukov SC; Campbell RL
    J Allergy Clin Immunol; 2013 Apr; 131(4):1103-8. PubMed ID: 23453138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pressure's on. A hypertension drug taken by 28 million people is under scrutiny. What are the other options?
    Smith IK
    Time; 2000 Sep; 156(11):126. PubMed ID: 11067229
    [No Abstract]   [Full Text] [Related]  

  • 26. [Chronotherapeutic evaluation of the antihypertensive treatment].
    Lemmer B
    Rev Esp Cardiol; 1999; 52 Suppl 3():45-52. PubMed ID: 10614149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of vasoactive therapy on cerebral circulation.
    Rhoney DH; Liu-DeRyke X
    Crit Care Clin; 2006 Apr; 22(2):221-43, vi. PubMed ID: 16677997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy for hypertension associated with heart failure].
    Miyamoto H; Imaizumi T
    Nihon Naika Gakkai Zasshi; 2003 Feb; 92(2):258-63. PubMed ID: 12652730
    [No Abstract]   [Full Text] [Related]  

  • 29. Antihypertensive drugs and fibrinolytic function.
    Fogari R; Zoppi A
    Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of antihypertensive therapy on left ventricular hypertrophy in essential hypertension.
    Frohlich ED
    Adv Nephrol Necker Hosp; 1990; 19():87-100. PubMed ID: 1967894
    [No Abstract]   [Full Text] [Related]  

  • 31. Resistant Hypertension: Which Agent?
    Prosser HCG; Azzam O; Schlaich MP
    Heart Lung Circ; 2018 Aug; 27(8):911-916. PubMed ID: 29526418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and trends in the drug treatment of essential hypertension.
    van Zwieten PA
    J Hypertens Suppl; 1992 Dec; 10(7):S1-12. PubMed ID: 1363322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rational approach to hypertension treatment in the older patient.
    Flack JM; Woolley A; Esunge P; Grimm RH
    Geriatrics; 1992 Nov; 47(11):24-8, 33-8. PubMed ID: 1358761
    [No Abstract]   [Full Text] [Related]  

  • 34. Approach to Antihypertensive Therapy.
    Reddy P; Dupree L
    Am J Ther; 2016; 23(2):e451-73. PubMed ID: 25719531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease.
    Huang RS; Cheng YM; Zeng XX; Kim S; Fu P
    Chin Med J (Engl); 2016 Mar; 129(5):562-9. PubMed ID: 26904991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of different blood-pressure-lowering regimens on major cardiac events.
    Steffen HM; Toex U; Kolloch R
    Lancet; 2004 Jan; 363(9405):331; author reply 331-2. PubMed ID: 14751718
    [No Abstract]   [Full Text] [Related]  

  • 37. Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers.
    Tazkarji B; Ganeshamoorthy A; Auten B
    Am Fam Physician; 2015 Feb; 91(3):193-4. PubMed ID: 25822274
    [No Abstract]   [Full Text] [Related]  

  • 38. Antihypertensive drugs in renal failure.
    Albert FW
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S108-12. PubMed ID: 7898089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy in hypertension.
    Gorostidi M; de la Sierra A
    Adv Ther; 2013 Apr; 30(4):320-36. PubMed ID: 23553510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.